Related references
Note: Only part of the references are listed.Current approaches to management of bone sarcoma in adolescent and young adult patients
Katrina M. Ingley et al.
PEDIATRIC BLOOD & CANCER (2022)
The potential role of the extracellular matrix in the activity of trabectedin in UPS and L-sarcoma: evidences from a patient-derived primary culture case series in tridimensional and zebrafish models
Alessandro De Vita et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
CDK4 overexpression is a predictive biomarker for resistance to conventional chemotherapy in patients with osteosarcoma
Shintaro Iwata et al.
ONCOLOGY REPORTS (2021)
Liquid Biopsies in Sarcoma Clinical Practice: Where Do We Stand?
Pia van der Laan et al.
BIOMEDICINES (2021)
PDGFRα marks distinct perivascular populations with different osteogenic potential within adipose tissue
Yiyun Wang et al.
STEM CELLS (2020)
Carcinoma and Sarcoma Microenvironment at a Glance: Where We Are
Mattia Saggioro et al.
FRONTIERS IN ONCOLOGY (2020)
MAFB Promotes Cancer Stemness and Tumorigenesis in Osteosarcoma through a Sox9-Mediated Positive Feedback Loop
Yanyan Chen et al.
CANCER RESEARCH (2020)
The role of extracelluar matrix in osteosarcoma progression and metastasis
Juncheng Cui et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Lysosomal protein surface expression discriminates fat-from bone-forming human mesenchymal precursor cells
Jiajia Xu et al.
ELIFE (2020)
A Feedback Loop between Hypoxia and Matrix Stress Relaxation Increases Oxygen-Axis Migration and Metastasis in Sarcoma
Daniel M. Lewis et al.
CANCER RESEARCH (2019)
Survival analysis of patients with metastatic osteosarcoma: a Surveillance, Epidemiology, and End Results population-based study
Kehan Song et al.
INTERNATIONAL ORTHOPAEDICS (2019)
Inactivation of Nell-1 in Chondrocytes Significantly Impedes Appendicular Skeletogenesis
Huichuan Qi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
The Effects of Systemic Therapy of PEGylated NEL-Like Protein 1 (NELL-1) on Fracture Healing in Mice
Justine Tanjaya et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
The Ewing Sarcoma Secretome and Its Response to Activation of Wnt/beta-catenin Signaling
Allegra G. Hawkins et al.
MOLECULAR & CELLULAR PROTEOMICS (2018)
NELL-1, HMGB1, and CCN2 Enhance Migration and Vasculogenesis, But Not Osteogenic Differentiation Compared to BMP2
Shorouk Fahmy-Garcia et al.
TISSUE ENGINEERING PART A (2018)
Targeting CD44 by CRISPR-Cas9 in Multi-Drug Resistant Osteosarcoma Cells
Zheng Xiao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Advances in sarcoma diagnostics and treatment
Amanda R. Dancsok et al.
ONCOTARGET (2017)
Current status of proteomics of soft tissue sarcomas
Tadashi Kondo
EXPERT REVIEW OF PROTEOMICS (2017)
Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers
Chaoyang Sun et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
NELL1, whose high expression correlates with negative outcomes, has different methylation patterns in alveolar and embryonal rhabdomyosarcoma
Lucia Tombolan et al.
ONCOTARGET (2017)
Extracellular matrix component signaling in cancer
Hinke A. B. Multhaupt et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Novel Wnt Regulator NEL-Like Molecule-1 Antagonizes Adipogenesis and Augments Osteogenesis Induced by Bone Morphogenetic Protein 2
Jia Shen et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Nel-like Molecule 1 Contributes to the Odontoblastic Differentiation of Human Dental Pulp Cells
Mengmeng Liu et al.
JOURNAL OF ENDODONTICS (2016)
Parathyroid hormone/parathyroid hormone-related peptide regulate osteosarcoma cell functions: Focus on the extracellular matrix
Dragana Nikitovic et al.
ONCOLOGY REPORTS (2016)
A systematic review and meta-analysis of MDM2 polymorphisms in osteosarcoma susceptibility
Nerea Bilbao-Aldaiturriaga et al.
PEDIATRIC RESEARCH (2016)
Vertebral Implantation of NELL-1 Enhances Bone Formation in an Osteoporotic Sheep Model
Aaron W. James et al.
TISSUE ENGINEERING PART A (2016)
NELL-1 expression in benign and malignant bone tumors
Jia Shen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma
Ritsuko Nakamura et al.
CANCER SCIENCE (2015)
Extracellular Matrix Glycoprotein-Derived Synthetic Peptides Differentially Modulate Glioma and Sarcoma Cell Migration
Nicole Broesicke et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2015)
Associations of chemo- and radio-resistant phenotypes with the gap junction, adhesion and extracellular matrix in a three-dimensional culture model of soft sarcoma
Chujie Bai et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
NELL-1 in the treatment of osteoporotic bone loss
Aaron W. James et al.
NATURE COMMUNICATIONS (2015)
CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma
Yan Gao et al.
SCIENTIFIC REPORTS (2015)
The impact of osteoblastic differentiation on osteosarcomagenesis in the mouse
T. Quist et al.
ONCOGENE (2015)
The regulation of MMP targeting to invadopodia during cancer metastasis
Abitha Jacob et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2015)
Genome-Wide Association Study of Genetic Predictors of Overall Survival for Non-Small Cell Lung Cancer in Never Smokers
Xifeng Wu et al.
CANCER RESEARCH (2013)
Diffusion MRI and Novel Texture Analysis in Osteosarcoma Xenotransplants Predicts Response to Anti-Checkpoint Therapy
Parastou Foroutan et al.
PLOS ONE (2013)
NELL-1 Injection Maintains Long-Bone Quantity and Quality in an Ovariectomy-Induced Osteoporotic Senile Rat Model
Jinny Kwak et al.
TISSUE ENGINEERING PART A (2013)
BMP2-Induced Inflammation Can Be Suppressed by the Osteoinductive Growth Factor NELL-1
Jia Shen et al.
TISSUE ENGINEERING PART A (2013)
PDGFs and PDGFRs in canine osteosarcoma: New targets for innovative therapeutic strategies in comparative oncology
Lorella Maniscalco et al.
VETERINARY JOURNAL (2013)
Nell-1 Enhances Bone Regeneration in a Rat Critical-Sized Femoral Segmental Defect Model
Weiming Li et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2011)
The Nell-1 Growth Factor Stimulates Bone Formation by Purified Human Perivascular Cells
Xinli Zhang et al.
TISSUE ENGINEERING PART A (2011)
The extracellular matrix at a glance
Christian Frantz et al.
JOURNAL OF CELL SCIENCE (2010)
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Kandice R. Levental et al.
CELL (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow
Masoud Soleimani et al.
NATURE PROTOCOLS (2009)
Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease
Carl R. Walkley et al.
GENES & DEVELOPMENT (2008)
Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage
Seth D. Berman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma
Z. Jin et al.
ONCOGENE (2007)
Markers of angiogenesis and clinical features in patients with sarcoma
Steven DuBois et al.
CANCER (2007)
Naturally produced extracellular matrix inhibits growth rate and invasiveness of human osteosarcoma cancer cells
V. Ivanov et al.
MEDICAL ONCOLOGY (2007)
Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects
J Desai et al.
HUMAN MOLECULAR GENETICS (2006)
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
G Bergers et al.
NATURE CELL BIOLOGY (2000)